# RCT on the Treatment of Menopausal Syndrome With Chinese Medicine

> **NCT06074809** · PHASE2 · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 78 (estimated)

## Conditions studied

- Menopause

## Interventions

- **DRUG:** Modified Guizhi Fuling granules
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06074809
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-01
- **Primary completion:** 2025-10-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2023-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06074809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06074809, "RCT on the Treatment of Menopausal Syndrome With Chinese Medicine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06074809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*